In Canada, prescription drugs can be sold only once they have successfully completed the drug review process and a notice of compliance (NOC) and drug identification number (DIN) have been issued. The Therapeutic Products Directorate of Health Canada will assess the safety, efficacy and quality of a drug; if it concludes that the benefits outweigh the risks, the drug will be issued an NOC and DIN.


Unlock unlimited access to all WTR content